热敏体的设计和表征,作为达乌诺鲁比输送平台

Viliana Gugleva1, Katerina Ahchiyska2, Elena Drakalska-Sersemova3

  • 1Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 84 Tsar Osvoboditel Str., 9000 Varna, Bulgaria.

PubMed
概括

这项研究开发了热敏的体,以改善鲁素化物输送. 这些纳米纤维增强了药物度在目标部位,减少了与这种化疗相关的心脏毒性.